Lowest-Rated StocksLowest-RatedNYSE:GSK GSK (GSK) News Today $34.71 +0.35 (+1.02%) (As of 03:10 PM ET) Add Compare Share Share Today's Range$34.37▼$34.7350-Day Range$33.60▼$38.3252-Week Range$28.47▼$44.75Volume1.96 million shsAverage Volume3.29 million shsMarket Capitalization$71.07 billionP/E Ratio4.19Dividend Yield3.92%Price TargetN/A HeadlinesProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.560.51▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼227▲GSK Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGSK employees to escalate strike action in June -unionmsn.com - June 8 at 11:03 AMGSK plc (NYSE:GSK) to Post Q4 2024 Earnings of $0.90 Per Share, Zacks Research Forecastsamericanbankingnews.com - June 8 at 8:32 AMGSK plc (NYSE:GSK) Shares Sold by Atria Wealth Solutions Inc.marketbeat.com - June 8 at 5:58 AMGSK plc (NYSE:GSK) Given Average Rating of "Hold" by Brokeragesamericanbankingnews.com - June 8 at 3:54 AMGSK Receives Authorization for RSV Vaccine From European Commissionmarketwatch.com - June 7 at 7:36 PMEU gives final approval for GSK's RSV vaccinemsn.com - June 7 at 7:36 PMGSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adultsfinance.yahoo.com - June 7 at 2:35 PMGSK wins EU approval for RSV vaccine Arexvyseekingalpha.com - June 7 at 9:35 AMZacks Research Analysts Lift Earnings Estimates for GSK plc (NYSE:GSK)marketbeat.com - June 7 at 5:57 AMUPDATE 1-EU authorises GSK's RSV vaccinefinance.yahoo.com - June 7 at 4:35 AMUS FDA accepts GSK's licence application for cancer treatment Jemperlilse.co.uk - June 6 at 1:33 PMGSK granted FDA priority review for label expansion in cancer drug Jemperlimsn.com - June 6 at 1:33 PMFDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decadesfinance.yahoo.com - June 6 at 1:33 PMFranklin Resources Inc. Has $1.74 Million Stock Holdings in GSK plc (NYSE:GSK)marketbeat.com - June 6 at 5:48 AMGSK Gets FDA File Acceptance For Jemperli Endometrial Cancer Treatmentmarketwatch.com - June 6 at 3:32 AMGSK's Cancer Drug Jemperli Gets File Acceptance From US FDAmoney.usnews.com - June 6 at 3:32 AMBank of America Corp DE Decreases Stock Position in GSK plc (NYSE:GSK)marketbeat.com - June 5 at 6:50 AMVictory Capital Management Inc. Invests $978,000 in GSK plc (NYSE:GSK)marketbeat.com - June 4 at 5:12 AMGSK plc (NYSE:GSK) Shares Sold by Renaissance Technologies LLCmarketbeat.com - June 2 at 1:50 PMDown 12% since April, the GSK share price fall looks overdone to meuk.finance.yahoo.com - June 1 at 1:42 PMGSK CEO Emma Walmsley says A.I. could improve Big Pharma’s most ‘profound’ challenge: R&D productivityfinance.yahoo.com - June 1 at 8:42 AMGSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the USfinance.yahoo.com - June 1 at 8:42 AMUS Approves Second RSV Vaccinebarrons.com - May 31 at 10:41 PMGSK’s CEO says you need thick skin if you’re going to step into the C-suitefortune.com - May 31 at 5:40 PMSei Investments Co. Raises Position in GSK plc (NYSE:GSK)marketbeat.com - May 29 at 7:37 AMGSK plc (NYSE:GSK) Stock Position Lowered by Kavar Capital Partners Group LLCmarketbeat.com - May 26 at 1:59 PMGucci-Owner Kering, Drugmaker GSK and Others Are Developing Global Targets on Nature Losswsj.com - May 25 at 7:37 AMGucci-Owner Kering, Drugmaker GSK and Others Are Developing a Global Standard on Nature Losswsj.com - May 25 at 7:37 AMMarket Digest: MKL, GSK, NFGfinance.yahoo.com - May 24 at 8:40 AMShare tip: A spoonful of GSK will help your profit go upthetimes.co.uk - May 20 at 10:34 PMScotia Capital Inc. Has $2.02 Million Stock Position in GSK plc (NYSE:GSK)marketbeat.com - May 19 at 7:59 AMGSK India reports Rs 133 crore net profitmsn.com - May 17 at 1:09 PMTempus Wealth Planning LLC Invests $679,000 in GSK plc (NYSE:GSK)marketbeat.com - May 17 at 10:39 AMGrabbing GSK For Buy Write Two Days Before It Trades Ex-Dividendforbes.com - May 16 at 5:06 PMBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisitionfinance.yahoo.com - May 16 at 5:06 PMTaika Capital LP Makes New Investment in GSK plc (NYSE:GSK)marketbeat.com - May 16 at 11:45 AMWhat To Expect From GSK In 2023seekingalpha.com - May 16 at 1:29 AMGSK: So, just how big is the RSV opportunity? Up to $9bn, says one brokerproactiveinvestors.com - May 15 at 1:31 PMIf I’d invested £5k in GSK shares one year ago here’s what I’d have todaymsn.com - May 15 at 8:31 AMGSK hails court ruling on claim of Zantac cancer linkthetimes.co.uk - May 12 at 8:04 PMGSK says Canadian court dismisses potential Zantac class suitmsn.com - May 12 at 10:03 AMBrokerages Set GSK plc (NYSE:GSK) Price Target at $1,533.00americanbankingnews.com - May 12 at 2:38 AMBRIEF-GSK Announces Intention To Sell Shares In Haleonmsn.com - May 12 at 1:16 AMGSK To Sell Up To 2.5% Of Haleon's Sharesmarkets.businessinsider.com - May 12 at 1:16 AMGSK to Sell $1 Billion Haleon Stake After Consumer Unit Spinoffbloomberg.com - May 11 at 3:15 PMGSK to sell 240 million shares in spin-off firm Haleonnews.yahoo.com - May 11 at 3:15 PMGSK plc (NYSE:GSK) Shares Bought by Prime Capital Investment Advisors LLCmarketbeat.com - May 11 at 6:50 AMFORA Capital LLC Reduces Holdings in GSK plc (NYSE:GSK)marketbeat.com - May 10 at 8:39 AMGSK plc (NYSE:GSK) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - May 9 at 3:44 AMRoanoke Asset Management Corp NY Sells 2,800 Shares of GSK plc (NYSE:GSK)marketbeat.com - May 8 at 12:22 PM Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zoetis News Today Regeneron Pharmaceuticals News Today Vertex Pharmaceuticals News Today Takeda Pharmaceutical News Today Genmab A/S News Today Alnylam Pharmaceuticals News Today Horizon Therapeutics Public News Today BeiGene News Today Sanofi News Today Bristol-Myers Squibb News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSE:GSK) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.